SK Hynix ADR Pricing Approaches as Seoul Stock's 17% Monthly Drop Adds Uncertainty
Taylor Wilson
SK Hynix's Nasdaq ADR is about to price, but its Seoul-listed shares have fallen 17% this month, squeezing what was expected to be a ~$29 billion raise — yet institutional subscriptions already exceed the offering size, making the final price a test of how underwriters balance volatility against demand.
How big is this deal, and why the sudden uncertainty?
SK Hynix plans to list ADRs — American Depositary Receipts, letting U.S. investors buy foreign stocks directly — on Nasdaq. The deal was initially expected to raise ~$29 billion, which would make it the largest-ever U.S. listing by a foreign company.
But its Seoul shares have dropped 17% this month, including ~9% since the July 3 close used as the reference price in the latest SEC filing. This means → the pricing benchmark is shrinking, and actual proceeds may fall short of the original target.
Final pricing will be based on Seoul's last traded price in the early afternoon New York time on July 9, along with prevailing market conditions and other factors.
Why has the Seoul stock fallen so sharply?
One key driver: rapid growth in leveraged exchange-traded products — funds that use borrowed money to amplify daily gains and losses — linked to SK Hynix.
NH Investment & Securities trader Roy Lim noted the impact of these products "should be distinguished from Hynix's fundamentals." In plain terms = the sharp swings reflect leveraged trading signals being amplified, not a deterioration in the company itself.
On Tuesday, Korea's KOSPI index fell 8% in a single session, triggering a circuit breaker. SK Hynix dropped over 6% that day — yet the stock is still up more than 700% over the past year.
Have institutional investors pulled back?
No. According to deal terms obtained by Bloomberg, investor interest in the ADR already exceeds the offering size.
Baillie Gifford, Coatue Management, and Situational Awareness Partners together indicated interest of up to $7 billion. This reflects that top institutions' long-term conviction on SK Hynix has not changed despite short-term volatility.
However, Clepsydra Capital founder Sanghyun Park noted that underwriters "may price slightly conservatively to ensure a strong Nasdaq debut." This means → demand is there, but the price may be deliberately set lower to leave room for a first-day pop.
Why do U.S. investors still want in?
White Oak Capital Partners CIO Nori Chiou offered a key reason: scarcity. Korean stocks, especially memory-chip names, remain "relatively scarce and hard to access" for U.S. investors.
In plain terms = U.S. institutions that want exposure to Korea's memory-chip champion have very few channels. The ADR is essentially the most direct entry point — and that "can't easily buy it" factor itself supports demand.
Fibonacci Asset Management Global CEO Jung In Yun said the current volatility "may affect short-term investor sentiment or execution timing," but added that "unless market conditions deteriorate significantly from here, the pricing impact should be manageable."
What to watch next?
The final price: whether underwriters set it conservatively will directly signal their read on market sentiment.
First-day trading: whether Nasdaq secondary-market performance can absorb the premium expectation is the key test of this deal's quality.
This means → a conservative price followed by a solid first-day gain would validate the underwriters' strategy; an aggressive price followed by a debut below the offering level would suggest volatility cut deeper than institutions expected.
Content is for reference only, not financial advice.